Skip to Main Content
TABLE 3

EGP and Rd in the basal state and during the last 40 min of the 80 mU · m–2 · min–1 hyperinsulinemic-euglycemic clamps in the 10 men and 8 women in the absence (control) and presence of an infusion of Intralipid and heparin (lipid) to raise plasma NEFA levels

Women
Men
ControlLipidControlLipid
Basal 
 EGP (mg · kg–1 · min–12.02 ± 0.08 2.01 ± 0.10 2.03 ± 0.10 2.13 ± 0.08 
End of clamp 
 EGP (mg · kg–1 · min–1−0.02 ± 0.09 0.61 ± 0.16* −0.11 ± 0.09 0.58 ± 0.11 
 Glucose Rd (mg · kg–1 · min–110.37 ± 1.11 9.89 ± 1.26 10.78 ± 0.52 8.37 ± 0.57 
Women
Men
ControlLipidControlLipid
Basal 
 EGP (mg · kg–1 · min–12.02 ± 0.08 2.01 ± 0.10 2.03 ± 0.10 2.13 ± 0.08 
End of clamp 
 EGP (mg · kg–1 · min–1−0.02 ± 0.09 0.61 ± 0.16* −0.11 ± 0.09 0.58 ± 0.11 
 Glucose Rd (mg · kg–1 · min–110.37 ± 1.11 9.89 ± 1.26 10.78 ± 0.52 8.37 ± 0.57 

Data are means ± SE. In the basal steady-state situation, glucose Rd is numerically equivalent to EGP.

*

P < 0.01,

P < 0.002,

P < 0.001 compared with the control study.

Close Modal

or Create an Account

Close Modal
Close Modal